Read More Pharma Industry News Iksuda Therapeutics advances IKS014 in Phase 1 trial following positive initial results Iksuda Therapeutics, a clinical-stage biotechnology firm from the UK specializing in innovative antibody drug conjugates (ADCs) for tumor… byPallavi MadhirajuOctober 24, 2023